CD40LG and dengue disease: The negative agreement of the VIDAS® Dengue assays with the competitor ELISA was high in the population naïve for DENV, with 152/175 (86.9%) for VIDAS® Anti-dengue IgM, 156/175 (89.1%) for VIDAS® Anti-dengue IgG, and 175/175 (100.0%) for VIDAS® Dengue NS1 Ag (Table 8).